Ensysce (ENSC) - Bathi pungkasan

The foundation of growth for Ensysce Biosciences (ENSC) is the development of abuse-deterrent opioids with long-term patent protection. The company's current profit, for which this chart provided in GURU.Markets confirms the potential, utilizes -0.01 as the base parameter value. This development is supported by an image as an innovator in safe pain management and a strong staff of clinical toxicology experts ensuring strict regulatory compliance.

Ensysce Biosciences, Inc. - Bathi resik ENSC (periode 04.07.2022 - 29.10.2026)

Rincian analitis lan laporan data perusahaan ensysce.com (ENSC)

- nilai saham lan prakiraan konsensus rega:

Rega bursa Ensysce Biosciences, Inc.|ENSC - Target konsensus

- indikator kapitalisasi pasar:

Nilai pasar Ensysce Biosciences, Inc.|ENSC - Nilai Perusahaan

- rincian valuasi buku bisnis:

Nilai Buku Saham Ensysce Biosciences|ENSC - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ensysce.com|ENSC - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Ensysce Biosciences|ENSC - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Ensysce Biosciences, Inc.|ENSC - Gunggung utang perusahaan|Utang-utang marang nilai buku Ensysce Biosciences, Inc.|ENSC - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Ensysce Biosciences|Koefisien jangkoan perantara ensysce.com

- rincian asil keuangan lan kelipatan valuasi:

ENSC - Penghasilan resik

Pambiji fundamental:ENSC Ensysce

Produk sing diprodhuksi Ensysce Biosciences Inc.

This indicator tracks daily net profit, providing a high-precision snapshot of actual cash flow without time lags to assess fundamental value. By analyzing the company's financial history, investors can see a direct correlation between capitalization and the commercialization of TAAP technology, as well as the ability of Ensysce Biosciences (ENSC) to secure FDA approval for the release of safe analgesics.

Pesaing utama